Ngā hua rapu - Aoïfe Lowery

Whakamahine hua
  1. 1
    Molecular and Therapeutic Advances in the Diagnosis and Management of Malignant Pheochromocytomas and Paragangliomas

    Molecular and Therapeutic Advances in the Diagnosis and Management of Malignant Pheochromocytomas and Paragangliomas mā Aoïfe Lowery, Siún Walsh, Enda McDermott, Ruth Prichard

    I whakaputaina 2013
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Dysregulated miR-183 inhibits migration in breast cancer cells

    Dysregulated miR-183 inhibits migration in breast cancer cells mā Aoïfe Lowery, Nicola Miller, Róisín M. Dwyer, Michael J. Kerin

    I whakaputaina 2010
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    Adipose-Derived Stem Cells in Novel Approaches to Breast Reconstruction: Their Suitability for Tissue Engineering and Oncological Safety

    Adipose-Derived Stem Cells in Novel Approaches to Breast Reconstruction: Their Suitability for Tissue Engineering and Oncological Safety mā Niamh O’Halloran, Donald Courtney, Michael J. Kerin, Aoïfe Lowery

    I whakaputaina 2017
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    MicroRNA Expression Profiles and Breast Cancer Chemotherapy

    MicroRNA Expression Profiles and Breast Cancer Chemotherapy mā Matthew G. Davey, Aoïfe Lowery, Nicola Miller, Michael J. Kerin

    I whakaputaina 2021
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    Hydrogels: 3D Drug Delivery Systems for Nanoparticles and Extracellular Vesicles

    Hydrogels: 3D Drug Delivery Systems for Nanoparticles and Extracellular Vesicles mā Yashna Chabria, Garry P. Duffy, Aoïfe Lowery, Róisín M. Dwyer

    I whakaputaina 2021
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  6. 6
    MicroRNAs as Novel Biomarkers for Breast Cancer

    MicroRNAs as Novel Biomarkers for Breast Cancer mā Helen Heneghan, Nicola Miller, Aoïfe Lowery, Keith Sweeney, Michael J. Kerin

    I whakaputaina 2009
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  7. 7
    MicroRNAs as Prognostic Indicators and Therapeutic Targets: Potential Effect on Breast Cancer Management

    MicroRNAs as Prognostic Indicators and Therapeutic Targets: Potential Effect on Breast Cancer Management mā Aoïfe Lowery, Nicola Miller, R.E. McNeill, Michael J. Kerin

    I whakaputaina 2008
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  8. 8
    Thyroid Lymphoma: Recent Advances in Diagnosis and Optimal Management Strategies

    Thyroid Lymphoma: Recent Advances in Diagnosis and Optimal Management Strategies mā Siún Walsh, Aoïfe Lowery, Denis Evoy, Enda McDermott, Ruth Prichard

    I whakaputaina 2013
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  9. 9
    The Role of MicroRNA as Clinical Biomarkers for Breast Cancer Surgery and Treatment

    The Role of MicroRNA as Clinical Biomarkers for Breast Cancer Surgery and Treatment mā Matthew G. Davey, Molly Davies, Aoïfe Lowery, Nicola Miller, Michael J. Kerin

    I whakaputaina 2021
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  10. 10
    Pathological complete response as a surrogate to improved survival in human epidermal growth factor receptor-2-positive breast cancer: systematic review and meta-analysis

    Pathological complete response as a surrogate to improved survival in human epidermal growth factor receptor-2-positive breast cancer: systematic review and meta-analysis mā Matthew G. Davey, Ferdia Browne, Nicola Miller, Aoïfe Lowery, Michael J. Kerin

    I whakaputaina 2022
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  11. 11
    Ki-67 as a Prognostic Biomarker in Invasive Breast Cancer

    Ki-67 as a Prognostic Biomarker in Invasive Breast Cancer mā Matthew G. Davey, Seán O. Hynes, Michael J. Kerin, Nicola Miller, Aoïfe Lowery

    I whakaputaina 2021
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  12. 12
    Identification of suitable endogenous control genes for microRNA gene expression analysis in human breast cancer

    Identification of suitable endogenous control genes for microRNA gene expression analysis in human breast cancer mā Pamela A Davoren, R.E. McNeill, Aoïfe Lowery, Michael J. Kerin, Nicola Miller

    I whakaputaina 2008
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  13. 13
    Combined breast conservation therapy versus mastectomy for BRCA mutation carriers – A systematic review and meta-analysis

    Combined breast conservation therapy versus mastectomy for BRCA mutation carriers – A systematic review and meta-analysis mā Matthew G. Davey, Ciara M. Davey, Éanna J. Ryan, Aoïfe Lowery, Michael J. Kerin

    I whakaputaina 2021
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  14. 14
    Haemoglobin A1c (HbA1C) in Non-diabetic and Diabetic Vascular Patients. Is HbA1C an Independent Risk Factor and Predictor of Adverse Outcome?

    Haemoglobin A1c (HbA1C) in Non-diabetic and Diabetic Vascular Patients. Is HbA1C an Independent Risk Factor and Predictor of Adverse Outcome? mā Conall O’Sullivan, Niamh Hynes, B. Mahendran, E. Andrews, G Avalos, S. Tawfik, Aoïfe Lowery, Sherif Sultan

    I whakaputaina 2006
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  15. 15
    Clinical utility of the 21-gene assay in predicting response to neoadjuvant endocrine therapy in breast cancer: A systematic review and meta-analysis

    Clinical utility of the 21-gene assay in predicting response to neoadjuvant endocrine therapy in breast cancer: A systematic review and meta-analysis mā Matthew G. Davey, Éanna J. Ryan, Michael R. Boland, M. Kevin Barry, Aoïfe Lowery, Michael J. Kerin

    I whakaputaina 2021
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  16. 16
    Preoperative imaging for focused parathyroidectomy: making a good strategy even better

    Preoperative imaging for focused parathyroidectomy: making a good strategy even better mā Carole Guérin, Aoïfe Lowery, S. Gabriel, Frédéric Castinetti, Mélanie Philippon, J. Vaillant-Lombard, Anderson Loundou, Jean‐François Henry, F. Sébag, David Taïeb

    I whakaputaina 2015
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  17. 17
    Use of Intraoperative Parathyroid Hormone in Minimally Invasive Parathyroidectomy for Primary Hyperparathyroidism

    Use of Intraoperative Parathyroid Hormone in Minimally Invasive Parathyroidectomy for Primary Hyperparathyroidism mā Alanna Jane Quinn, Éanna J. Ryan, Stephen Garry, Danielle L. James, Michael R. Boland, Orla Young, Michael J. Kerin, Aoïfe Lowery

    I whakaputaina 2020
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  18. 18
    Optimal localization strategies for non-palpable breast cancers –A network meta-analysis of randomized controlled trials

    Optimal localization strategies for non-palpable breast cancers –A network meta-analysis of randomized controlled trials mā Matthew G. Davey, John P. O'Donnell, Michael R. Boland, Éanna J. Ryan, Stewart R. Walsh, Michael J. Kerin, Aoïfe Lowery

    I whakaputaina 2022
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  19. 19
    Breast cancer recurrence: factors impacting occurrence and survival

    Breast cancer recurrence: factors impacting occurrence and survival mā Donald Courtney, Matthew G. Davey, Brian Moloney, Michael Kevin Barry, Karl Sweeney, Ray McLaughlin, Carmel Malone, Aoïfe Lowery, Michael J. Kerin

    I whakaputaina 2022
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  20. 20
    MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2/neureceptor status in breast cancer

    MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2/neureceptor status in breast cancer mā Aoïfe Lowery, Nicola Miller, A. Devaney, R.E. McNeill, Pamela A Davoren, Christophe Lemetre, Vladimı́r Beneš, Sabine Schmidt, Jonathon Blake, Graham Ball, Michael J. Kerin

    I whakaputaina 2009
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: